Human testing begins on NewLink Genetics’ Ebola vaccine
(Reuters) -- Human testing of an experimental Ebola vaccine developed by the Canadian health agency and licensed to NewLink Genetics Corp has begun, the Canadian…
12 years ago
This website uses cookies.